We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Information for Clinicians: Approach to the Patient with Progressive Radioiodine-Refractory Thyroid Cancer-When to Use Systemic Therapy.
- Authors
Cabanillas, Maria E.; Terris, David J.; Sabra, Mona M.
- Abstract
The article focuses on the approach to the patient with progressive radioiodine (RAI) refractory thyroid cancer. When evaluating a patient with disease progression after RAI therapy, several critical questions need to be addressed in order to determine the most appropriate management. The first step in evaluating a patient’s eligibility for MKI therapy is determining whether the patient has convincing evidence of RAI-R disease or not.
- Subjects
IODINE isotopes; INCURABLE diseases; ONCOLOGY; THYROID cancer; CARCINOGENS
- Publication
Thyroid, 2017, Vol 27, Issue 8, p987
- ISSN
1050-7256
- Publication type
Article
- DOI
10.1089/thy.2016.0578